USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 34,226 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $57.51, for a total transaction of $1,968,337.26. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

USANA Health Sciences, Inc. (USNA) traded down 0.61% during trading on Friday, hitting $57.00. 185,419 shares of the stock traded hands. The company has a market cap of $1.39 billion, a P/E ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $75.00. The company’s 50 day moving average price is $57.59 and its 200 day moving average price is $60.18.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.06 by ($0.08). USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The firm had revenue of $257.10 million for the quarter, compared to analyst estimates of $273.61 million. During the same quarter last year, the business posted $2.07 earnings per share. The firm’s revenue for the quarter was down .5% compared to the same quarter last year. On average, equities research analysts anticipate that USANA Health Sciences, Inc. will post $3.79 EPS for the current fiscal year.

USANA Health Sciences declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, July 25th that permits the company to buyback $64.60 million in outstanding shares. This buyback authorization permits the company to purchase up to 46% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/09/15/usana-health-sciences-inc-usna-director-sells-1968337-26-in-stock.html.

Hedge funds have recently modified their holdings of the company. American International Group Inc. increased its position in shares of USANA Health Sciences by 7.1% during the 1st quarter. American International Group Inc. now owns 6,392 shares of the company’s stock valued at $368,000 after purchasing an additional 422 shares during the period. Prudential Financial Inc. increased its position in shares of USANA Health Sciences by 22.4% during the 1st quarter. Prudential Financial Inc. now owns 69,763 shares of the company’s stock valued at $4,019,000 after purchasing an additional 12,757 shares during the period. Schroder Investment Management Group increased its position in shares of USANA Health Sciences by 9.0% during the 2nd quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock valued at $36,734,000 after purchasing an additional 47,448 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of USANA Health Sciences during the 1st quarter valued at $515,000. Finally, JPMorgan Chase & Co. increased its position in shares of USANA Health Sciences by 1.2% during the 1st quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after purchasing an additional 196 shares during the period. Institutional investors own 44.90% of the company’s stock.

USNA has been the topic of several recent analyst reports. BidaskClub downgraded shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Tuesday, June 20th. Pivotal Research cut their price objective on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a report on Wednesday, July 26th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.